Skip to main content
ISET 2026

Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System

In this video, interventional cardiologist William A. Gray, MD, FACC, MSCAI, from Lankenau Heart Group in Wynnewood, Pennsylvania, highlights the key findings from his presentation at ISET 2026, “Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System”. Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into the safety, efficacy, and sustained performance of this novel integrated embolic protection carotid stent system in the treatment of carotid artery stenosis.


© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.